Anaesthetics and cardiac preconditioning. Part II. Clinical implications

British Journal of Anaesthesia

Volumn 91, Issue 4, 2003, Pages 566-576

  Zaugg, Michael ^a,c   Lucchinetti, E ^c   Garcia, C ^a   Pasch, T ^a   Spahn, D R ^b   Schaub, M C ^c  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^b UNIVERSITY OF LAUSANNE   (Switzerland)

^c UNIVERSITY OF ZURICH   (Switzerland)

Author keywords

Anaesthesia, perioperative; Heart, cardiac preconditioing, cardioprotection

Indexed keywords

ADENOSINE; ADENOSINE RECEPTOR BLOCKING AGENT; ALPHA ADRENERGIC RECEPTOR; AMINOPHYLLINE; ANESTHETIC AGENT; BAMIFYLLINE; BRADYKININ; CISATRACURIUM; DIAZEPAM; ENFLURANE; FENTANYL; FLUNITRAZEPAM; GLYCERYL TRINITRATE; INHALATION ANESTHETIC AGENT; ISOFLURANE; KETAMINE; MIDAZOLAM; MORPHINE; NALOXONE; NICORANDIL; OPIATE RECEPTOR; PANCURONIUM; PHENTOLAMINE; POTASSIUM CHANNEL; POTASSIUM CHANNEL BLOCKING AGENT; PROPOFOL; SEVOFLURANE; SUFENTANIL; SULFONYLUREA; THIOPENTAL; UNINDEXED DRUG;

ADAPTATION; AGING; ANESTHESIOLOGICAL TECHNIQUES; CLINICAL PRACTICE; CLINICAL TRIAL; DRUG POTENCY; HEART DISEASE; HEART FUNCTION; HEART INFARCTION PREVENTION; HEART MITOCHONDRION; HEART MUSCLE FIBER MEMBRANE; HEART MUSCLE ISCHEMIA; HEART SURGERY; HUMAN; MYOCARDIAL DISEASE; OUTCOMES RESEARCH; PERIOPERATIVE PERIOD; PRIORITY JOURNAL; REVIEW;

EID: 0141996987     PISSN: 00070912     EISSN: None     Source Type: Journal    
DOI: 10.1093/bja/aeg206     Document Type: Review

References (114)

1. Abete P, Ferrara N, Cacciatore F, et al. Angina-induced protection against myocardial infarction in adult and elderly patients: a loss of preconditioning mechanism in the aging heart? J Am Coll Cordiol 1997; 30: 947-54
2. Aitchison KA, Baxter GF, Awan MM, Smith RM, Yellon DM, Opie LH. Opposing effects on infarction of delta and kappa opioid receptor activation in the isolated rat heart: implications for ischemic preconditioning. Basic Res Cordiol 2000; 95: 1-10
3. Belhomme D, Peynet J, Louzy M, Launay JM, Kitakaze M, Menasche P. Evidence for preconditioning by isoflurane in coronary artery bypass graft surgery. Circulation 1999; 100: 11340-4
4. Bolli R. The late phase of preconditioning. Circ Res 2000; 87: 972-83
5. Boutros A, Wang J. Ischemic preconditioning, adenosine and bethanechol protect spontaneously hypertensive isolated rat hearts. J Pharmacol Exp Ther 1995; 275: 1148-56
6. Bukhari EA, Krukenkamp IB, Burns PG, et al. Does aprotinin increase the myocardial damage in the setting of ischemia and preconditioning? Ann Thorac Surg 1995; 60: 307-10
7. Burckhartt B, Yang XM, Tsuchida A, Mullane KM, Downey JM, Cohen MV. Acadesine extends the window of protection afforded by ischaemic preconditioning in conscious rabbits. Cardiovasc Res 1995; 29: 653-7
8. Burns PG, Krukenkamp IB, Caldarone CA, Gaudette GR, Bukhari EA, Levitsky S. Does cardiopulmonary bypass alone elicit myoprotective preconditioning? Circulation 1995; 92: 11447-51
9. Butler KL, Huang AH, Gwathmey JK. ATI-receptor blockade enhances ischemic preconditioning in hypertrophied rat myocardium. Am J Physiol 1999; 277: H2482-7
10. Carr CS, Yellon DM. Ischaemic preconditioning may abolish the protection afforded by ATP-sensitive potassium channel openers in isolated human atrial muscle. Basic Res Cardiol 1997; 92: 252-60
11. Carroll R, Yellon DM. Delayed cardioprotection in a human cardiomyocyte-derived cell line: the role of adenosine, p38MAP kinase and mitochondrial KATP. Basic Res Cardiol 2000; 95: 243-9
12. Cave AC, Hearse DJ. Ischaemic preconditioning and contractile function: studies with normothermic and hypothermic global ischemia. J Mol Cell Cardiol 1992; 24: 1113-23
13. Cleveland JC Jr, Meldrum DR, Cain BS, Banerjee A, Harken AH. Oral sulfonylurea hypoglycemic agents prevent ischemic preconditioning in human myocardium. Two paradoxes revisited. Circulation 1997; 96: 29-32
14. Dana A, Baxter GF, Walker JM, Yellon DM. Prolonging the delayed phase of myocardial protection: repetitive adenosine A1 receptor activation maintains rabbit myocardium in a preconditioned state. J Am Coll Cardiol 1998; 31: 1142-9
15. Dana A, Carroll R, Walker JM, Yellon DM. Exercise induced ischemia causes both early and delayed myocardial adaptation during repeated exercise: a role for adenosine (abstract). Eur Heart J 2000; 21 [Suppl.]: 366
16. De Hert SG, ten Broecke PW, Martens E, et al. Sevoflurane but not propofol preserves myocardial function in coronary surgery patients. Anesthesiology 2002; 97: 42-9
17. de Klaver MJ, Manning L, Palmer LA, Rich GF. Isoflurane pretreatment inhibits cytokine-induced cell death in cultured rat smooth muscle cells and human endothelial cells. Anesthesiology 2002; 97: 24-32
18. Deutsch E, Berger M, Kussmaul WG, Hirshfeld JW Jr, Herrmann HC, Laskey WK. Adaptation to ischemia during percutaneous transluminal coronary angioplasty. Clinical, hemodynamic, and metabolic features. Circulation 1990; 82: 2044-51
19. Dupouy P, Geschwind H, Pelle G, et al. Repeated coronary artery occlusions during routine balloon angioplasty do not induce myocardial preconditioning in humans. J Am Coll Cardiol 1996; 27: 1374-80
20. Garratt KN, Brady PA, Hassinger NL, Grill DE, Terzic A, Holmes DR. Sulfonylurea drugs increase early mortality in patients with diabetes after direct angioplasty for acute myocardial infarction. J Am Coll Cardiol 1999; 33: 119-24
21. Ghosg S, Standen NB, Galinanes M. Failure to precondition pathological human myocardium. J Am Coll Cardiol 2001; 37: 711-8
22. Group UPDSU. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 1998; 352: 837-53
23. Han J, Kim E, Ho WK, Earm YE. Effects of volatile anesthetic isoflurane on ATP-sensitive K+ channels in rabbit ventricular myocytes. Biochem Biophys Res Commun 1996; 229: 8524
24. Hanouz J, Yvon A, Massetti M, et al. Mechanisms of desflurane-induced preconditioning in isolated human right atria in vitro. Anesthesiology 2002; 97: 33-41
25. Haroun-Bizri S, Khoury SS, Chehab IR, Kassas CM, Baraka A. Does isoflurane optimize myocardial protection during cardiopulmonary bypass? J Cardiothorac Vasc Anesth 2001; 15: 418-21
26. Haruna T, Horie M, Kouchi I, et al. Coordinate interaction between ATP-sensitive K+ channel and Na+,K+-ATPase modulates ischemic preconditioning. Circulation 1998; 98: 2905-10
27. Heurteaux C, Lauritzen I, Widmann C, Lazdunski M. Essential role of adenosine, adenosine A1 receptors, and ATP-sensitive K channels in cerebral ischemic preconditioning. Pharmacology 1996; 92: 4666-70
28. Horimoto H, Saltman AE, Gaudette GR, Krukenkamp IB. Nitric oxide-generating beta-adrenergic blocker nipradilol preserves postischemic function. Ann Thorac Surg 1999; 68: 844-9
29. Ikonomidis JS, Shirai T, Weisel RD, et al. Preconditioning cultured human pediatric myocytes requires adenosine and protein kinase C. Am J Physiol 1997; 272: H1220-30
30. Illes RW, Swoyer KD. Prospective, randomized clinical study of ischemic preconditioning as an adjunct to intermittent cold blood cardioplegia. Ann Thorac Surg 1998; 65: 748-52
31. Ishihara M, Sato H, Tateishi H, et al. Implications of prodromal angina pectoris in anterior wall acute myocardial infarction: acute angiographic findings and long-term prognosis. J Am Coll Cardiol 1997; 30: 970-5
32. Ishihara M, Sato H, Tateishi H, et al. Beneficial effect of prodromal angina pectoris is lost in elderly patients with acute myocardial infarction. Am Heart J 2000; 139: 881-8
33. Jacobson E, Young CJ, Aronson S, Ferdinand FD, Albertucci M. The role of ischemic preconditioning during minimally invasive coronary artery bypass surgery. J Cardiothorac Vasc Anesth 1997; 11: 787-92
34. Jenkins DP, Pugsley WB, Alkhulaifi AM, Kemp M, Hooper J, Yellon DM. Ischaemic preconditioning reduces troponin T release in patients undergoing coronary artery bypass surgery. Heart 1997; 77: 314-8
35. Jimenez-Navarro M, Gomez-Doblas JJ, Alonso-Briales J, et al. Does angina the week before protect against first myocardial infarction in elderly patients? Am J Cardiol 2001; 87: 11-5
36. Kaneko T, Saito Y, Hikawa Y, Yasuda K, Makita K. Dose-dependent prophylactic effect of nicorandil, an ATP-sensitive potassium channel opener, on intra-operative myocardial ischemia in patients undergoing major abdominal surgery. Br J Anaesth 2001; 86: 332-7
37. Kawano T, Oshita S, Tsutsumi Y, et al. Clinically relevant concentrations of propofol have no effect on adenosine triphosphate-sensitive potassium channels in rat ventricular myocytes. Anesthesiology 2002; 96: 1472-7
38. Kersten JR, Montgomery MW, Ghassemi T, et al. Diabetes and hyperglycemia impair activation of mitochondrial KATP channels. Am J Physiol Heart Circ Physiol 2001; 280: H1744-50
39. Kersten JR, Montgomery MW, Pagel PS, Warltier DC. Levosimendan, a new positive inotropic drug, decreases myocardial infarct size via activation of K(ATP) channels. Anesth Analg 2000; 90: 5-11
40. Kevelaitis E, Oubenaissa A, Peynet J, Mouas C, Menasche P. Preconditioning by mitochondrial ATP-sensitive potassium channel openers: an effective approach for improving the preservation of heart transplants. Circulation 1999; 100: 11345-50
41. Klepzig H, Kober G, Matter C, et al. Sulfonylureas and ischaemic preconditioning; a double-blind, placebo-controlled evaluation of glimepiride and glibenclamide. Eur Heart J 1999; 20: 439-46
42. Kloner RA, Shook T, Przyklenk K, et al. Previous angina alters in-hospital outcome in TIMI 4. A clinical correlate to preconditioning? Circulation 1995; 91: 37-45
43. Ko SH, Lee SK, Han YJ, et al. Blockade of myocardial ATP-sensitive potassium channels by ketamine. Anesthesiology 1997; 87: 68-74
44. Kohro S, Hogan QH, Nakae Y, Yamakage M, Bosnjak ZJ. Anesthetic effects on mitochondrial ATP-sensitive K channel. Anesthesiology 2001; 95: 1435-40
45. Laskey WK. Beneficial impact of preconditioning during PTCA on creatine kinase release. Circulation 1999; 99: 2085-9
46. Laurikka J, Wu Z-K, Lisalo P, et al. Regional ischemic preconditioning enhances myocardial performance in off-pump coronary artery bypass grafting. Chest 2002; 121: 1183-9
47. Ledoux S, Laouari D, Essig M, et al. Lovastatin enhances Ecto-5′-nucleotidase activity and cell surface expression in endothelial cells: implication of Rho-family GTPases. Circ Res 2002; 90: 420-7
48. Lee TM, Su SF, Chou TF, Lee YT, Tsai CH. Loss of preconditioning by attenuated activation of myocardial ATP-sensitive potassium channels in elderly patients undergoing coronary angioplasty. Circulation 2002; 105: 334-40
49. Leesar MA, Stoddard M, Ahmed M, Broadbent J, Bolli R. Preconditioning of human myocardium with adenosine during coronary angioplasty. Circulation 1997; 95: 2500-7
50. Leesar MA, Stoddard MF, Dawn B, Jasti VG, Masden R, Bolli R. Delayed preconditioning-mimetic action of nitroglycerin in patients undergoing coronary angioplasty. Circulation 2001; 103: 2935-41
51. Leesar MA, Stoddard MF, Manchikalapudi S, Bolli R. Bradykinin-induced preconditioning in patients undergoing coronary angioplasty. J Am Coll Cardiol 1999; 34: 639-50
52. Li G, Chen S, Lu E, Luo W. Cardiac ischemic preconditioning improves lung preservation in valve replacement operations. Ann Thorac Surg 2001; 71: 631-5
53. Li G, Tokuno S, Tahep Id P, Vaage J, Lowbeer C, Valen G. Preconditioning protects the severely atherosclerotic mouse heart. Ann Thorac Surg 2001; 71: 1296-303; discussion 1303-4
54. Liu Y, Thornton JD, Cohen MV, Downey JM, Schaffer SW. Streptozotocin-induced non-insulin-dependent diabetes protects the heart from infarction. Circulation 1993; 88: 1273-8
55. Lochner A, Genade S, Tromp E, Podzuweit T, Moolman JA. Ischemic preconditioning and the beta-adrenergic signal transduction pathway. Circulation 1999; 100: 958-66
56. Lu EX, Chen SX, Hu TH, Xui LM, Yuan MD. Preconditioning enhances myocardial protection in patients undergoing open heart surgery. Thorac Cardiovasc Surg 1998; 46: 28-32
57. Lucchetti V, Caputo M, Suleiman M-S, Capece M, Brando G, Angelini GD. Beating heart coronary revascularisation without metabolic myocardial damage. Eur J Cardiothorac Surg 1998; 14: 443-4
58. Malkowski MJ, Kramer CM, Taher Parvizi S, et al. Transient ischemia does not limit subsequent ischemic regional dysfunction in humans: a transesophageal echocardiographic study during minimally invasive coronary artery bypass surgery. J Am Coll Cardiol 1998; 31: 1035-9
59. Mangano DT. Effects of acadesine on myocardial infarction, stroke, and death following surgery. JAMA 1997; 277: 325-32
60. Mangano DT, Layug EL, Wallace A, Tateo I. Effect of atenolol on mortality and cardiovascular morbidity after noncardiac surgery. Multicenter Study of Perioperative Ischemia Research Group (see comments). [Published erratum appears in N Engl J Med 1997; 336: 1039]. N Engl J Med 1996; 335: 1713-20
61. Meinert CL, Knatterud GL, Prout TE, Klimt CR. A study of the effects of hypoglycemic agents on vascular complications in patients with adult-onset diabetes. II. Mortality results. Diabetes 1970; 19: 789-830
62. 2+ as a mediator of ischemic preconditioning. Circ Res 1997; 80: 790-9
63. Müllenheim J, Frässdorf J, Preckel B, Thämer V, Schlack W. Ketamine, but not S(+)-ketamine, blocks ischemic preconditioning in rabbit hearts in vivo. Anesthesiology 2001; 94: 630-6
64. Müllenheim J, Rulands R, Wietschorke T, Frassdorf J, Preckel B, Schlack W. Late preconditioning is blocked by racemic ketamine, but not by S(+)-ketamine. Anesth Analg 2001; 93: 265-70
65. Okazaki Y, Kodama K, Sato H, et al. Attenuation of increased regional myocardial oxygen consumption during exercise as a major cause of warm-up phenomenon. J Am Coll Cardiol 1993; 21: 1597-604
66. Oliveira PJ, Rolo AP, Sardao VA, Coxito PM, Palmeira CM, Moreno AJ. Carvedilol in heart mitochondria: protonophore or opener of the mitochondrial K(ATP) channels? Life Sci 2000; 69: 123-32
67. Osborne DL, Aw TY, Cepinskas G, Kvietys PR. Development of ischemia/reperfusion tolerance in the rat small intestine. An epithelium-independent event. J Clin Invest 1994; 94: 1910-8
68. Ottani F, Galvani M, Ferrini D, et al. Prodromal angina limits infarct size. A role for ischemic preconditioning. Circulation 1995; 91: 291-7
69. Pabst SJ, Lust RM, Jolly SR. Disparate effects of ischemic preconditioning in left ventricular hypertrophy. Circulation 1993; 88: 1-538
70. Pasini FL, Guideri F, Ferber D, et al. Pharmacological preconditioning of ischemic heart disease by low-dose dipyridamole. Int J Cardiol 1996; 56: 17-27
71. Patel DJ, Purcell HJ, Fox KM. Cardioprotection by opening of the K(ATP) channel in unstable angina. Is this a clinical manifestation of myocardial preconditioning? Results of a randomized study with nicorandil. CESAR 2 investigation. Clinical European studies in angina and revascularization. Eur Heart J 1999; 20: 51-7
72. Penta de Peppo A, Polisca P, Tomai F, et al. Recovery of LV contractility in man is enhanced by preischemic administration of enflurane. Ann Thorac Surg 1999; 68: 112-28
73. Peralta C, Closa D, Xaus C, Gelpi E, Rosello-Catafau J, Hotter G. Hepatic preconditioning in rats is defined by a balance of adenosine and xanthine. Hepatology 1998; 28: 768-73
74. Perrault LP, Menasche P, Bel A, et al. Ischemic preconditioning in cardiac surgery: a word of caution. J Thorac Cardiovasc Surg 1996; 112: 1378-86
75. Piriou V, Chiari P, Knezynski S, et al. Prevention of isoflurane-induced preconditioning by 5-hydroxydecanoate and gadolinium: possible involvement of myocardial adenosine triphosphate-sensitive potassium and stretch-activated channels. Anesthesiology 2000; 93: 756-64
76. Poldermans D, Boersma E, Bax JJ, et al. The effect of bisoprolol on perioperative mortality and myocardial infarction in high-risk patients undergoing vascular surgery. Dutch Echocardiographic Cardiac Risk Evaluation Applying Stress Echocardiography Study Group. N Engl J Med 1999; 341: 1789-94
77. Randall MD, Gardiner SM, Bennett T. Enhanced cardiac preconditioning in the isolated heart of the transgenic ((mREN-2) 27) hypertensive rat. Cardiovasc Res 1997; 33: 400-9
78. Roscoe AK, Christensen JD, Lynch C. Isoflurane, but not halothane, induces protection of human myocardium via adenosine A1 receptors and adenosine triphosphate-sensitive potassium channels. Anesthesiology 2000; 92: 1692-701
79. Saltman AE, Gaudette GR, Levitsky S, Krukenkamp IB. Amrinone preconditioning in the isolated perfused rabbit heart. Ann Thorac Surg 2000; 70: 609-13
80. Schultz JE, Hsu AK, Gross GJ. Morphine mimics the cardioprotective effect of ischemic preconditioning via a glibenclamide-sensitive mechanism in the rat heart. Circ Res 1996; 78: 1100-4
81. Schulz R, Post H, Vahlhaus C, Heusch G. Ischemic preconditioning in pigs: a graded phenomenon: its relation to adenosine and bradykinin. Circulation 1998; 98: 1022-9
82. Scognamiglio R, Avogaro A, Vigili de Kreutzenberg S, et al. Effects of treatment with sulfonylurea drugs or insulin on ischemia-induced myocardial dysfunction in type 2 diabetes. Diabetes 2002; 51: 808-12
83. Speechly-Dick ME, Baxter GF, Yellon DM. Ischaemic preconditioning protects hypertrophied myocardium. Cardiovasc Res 1994; 28: 1025-9
84. Szewczyk A, Wojtczak L. Mitochondria as a pharmacological target. Pharmacol Rev 2002; 54: 101-27
85. Szilvassy Z, Ferdinandy P, Szilvassy J, et al. The loss of pacing-induced preconditioning in atherosclerotic rabbits: role of hypercholesterolaemia. J Mol Cell Cardiol 1995; 27: 2559-69
86. Tanaka K, Kehl F, Gu W, et al. Isoflurane-induced preconditioning is attenuated by diabetes. Am J Physiol Heart Circ Physiol 2002; 282: H2018-23
87. Tani M, Honma Y, Hasegawa H, Tamaki K. Direct activation of mitochondrial K(ATP) channels mimics preconditioning but protein kinase C activation is less effective in middle-aged rat hearts. Cardiovasc Res 2001; 49: 56-68
88. Tani M, Suganuma Y, Hasegawa H, et al. Changes in ischemic tolerance and effects of ischemic preconditioning in middle-aged rat hearts. Circulation 1997; 95: 2559-66
89. Tatsumi T, Matoba S, Kobara M, et al. Energy metabolism after ischemic preconditioning in streptozotocin-induced diabetic rat hearts. J Am Coll Cardiol 1998; 31: 707-15
90. Tomai F, Crea F, Gaspardone A, et al. Effects of A1 adenosine receptor blockade by bamiphylline on ischaemic preconditioning during coronary angioplasty. Eur Heart J 1996; 17: 846-53
91. Tomai F, Crea F, Gaspardone A, et al. Phentolamine prevents adaptation to ischemia during coronary angioplasty: role of alpha-adrenergic receptors in ischemic preconditioning. Circulation 1997; 96: 2171-7
92. Tomai F, Crea F, Gaspardone A, et al. Effects of naloxone on myocardial ischemic preconditioning in humans. J Am Coll Cardiol 1999; 33: 1863-9
93. Tomai F, De Paulis R, Penta de Peppo A, et al. Beneficial impact of isoflurane during coronary bypass surgery on troponin I release. G Ital Cardiol 1999; 29: 1007-14
94. Toombs CF, Wiltse AL, Shebuski RJ. Ischemic preconditioning fails to limit infarct size in reserpinized rabbit myocardium. Implication of norepinephrine release in the preconditioning effect. Circulation 1993; 88: 2351-8
95. Torras J, Herrero-Fresneda I, Iloberas N, Riera M, Cruzado JM, Grinyo JM. Promising effects of ischemic preconditioning in renal transplantation. Kidney Int 2002; 61: 2218-27
96. Tosaki A, Pali T, Droy-Lefaix MT. Effects of Ginkgo biloba extract and preconditioning on the diabetic rat myocardium. Diabetologia 1996; 39: 1255-62
97. Toyoda Y, Di Gregorio V, Parker RA, Levitsky S, McCully JD. Anti-stunning and anti-infarct effects of adenosine-enhanced ischemic preconditioning. Circulation 2000; 102: III326-31
98. Tsutsumi Y, Oshita S, Kawano T, et al. Lidocaine and mexiletine inhibit mitochondrial oxidation in rat ventricular myocytes. Anesthesiology 2001; 95: 766-70
99. Tsutsumi Y, Oshita S, Kitahata H, Kuroda Y, Kawano T, Nakaya Y. Blockade of adenosine triphosphate-sensitive potassium channels by thiamylal in rat ventricular myocytes. Anesthesiology 2000; 92: 1154-9
100. Tuman KJ, McCarthy RJ, Spiess BD, DaValle M, Dabir R, Ivankovich AD. Does choice of anesthetic agent significantly affect outcome after coronary artery surgery? Anesthesiology 1989; 70: 189-98
101. Wang S, Cone J, Liu Y. Dual role of mitochondrial KATP channels in diazoxide-mediated protection in isolated rabbit hearts. Am J Physiol Heart Circ Physiol 2001; 280: H246-56
102. Wang Y, Ashraf M. Activation of alpha1-adrenergic receptor during Ca2+ pre-conditioning elicits strong protection against Ca2+ overload injury via protein kinase C signaling pathway. J Mol Cell Cardiol 1998; 30: 2423-35
103. Wikstrom BG, Ronquist G, Waldenstrom A. No further improvement of ischaemic myocardial metabolism by combining preconditioning with beta-blockade: an in vivo experimental study in the pig heart using a microdialysis technique. Acta Physiol Scand 1997; 159: 23-32
104. Yabe K, Ishishita H, Tanonaka K, Takeo S. Pharmacologic preconditioning induced by beta-adrenergic stimulation is mediated by activation of protein kinase C. J Cardiovasc Pharmacol 1998; 32: 962-8
105. Yang XM, Arnoult S, Tsuchida A, et al. The protection of ischaemic preconditioning can be reinstated in the rabbit heart after the initial protection has waned. Cardiovasc Res 1993; 27: 556-8
106. Yao Z, McPherson BC, Liu H, et al. Signal transduction of flumazenil-induced preconditioning in myocytes. Am J Physiol Heart Circ Physiol 2001; 280: H1249-55
107. Zaugg M, Lucchinetti E, Spahn DR, Pasch T, Garcia C, Schaub MC. Differential effects of anesthetics on mitochondrial KATP channel activity and cardiomyocyte protection. Anesthesiology 2002; 97: 15-23
108. Zaugg M, Lucchinetti E, Uecker M, Pasch T, Schaub MC. Anaesthetics and cardiac preconditioning. Part I. Signalling and cytoprotective mechanisms. Br J Anaesth 2003; 91: 551-65
109. Zaugg M, Schaub MC, Pasch T, Spahn DR. Modulation of beta-adrenergic receptor subtype activities in perioperative medicine: mechanisms and sites of action. Br J Anaesth 2002; 88: 101-23
110. Zaugg M, Tagliente T, Lucchinetti E, et al. Beneficial effects from beta-adrenergic blockade in elderly patients undergoing noncardiac surgery. Anesthesiology 1999; 91: 1674-86
111. Julier K, da Silva R, Garcia C, et al. Preconditioning by sevoflurane decreases biochemical markers for myocardial and renal dysfunction in coronary artery bypass graft surgery: a double-blinded placebo-controlled multicenter study. Anesthesiology 2003; 98: 1315-27
112. Pouzet B, Lecharny JB, Paquin S, Kitakaze M, Mantz J, Menache P. Is there a place for preconditioning during cardiac operation in humans? Ann Thorac Surg 2002; 73: 843-8
113. ATP channels activated by conjugated estrogens in the regulation of myocardial and coronary protective effects. Circulation 2002; 107: 49-54
114. ATP channels in rabbits. Am J Physiol 2002; 283: H1263-9